FDAJune 6, 2023device

Vanta with AdaptiveStim Implantable Neurostimulator, Model 977006; spinal chord stimulation

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

A cardioversion procedure may damage the electronics in the Vanta INS device, making the INS unresponsive and non-functional. As of April 19, 2023, Medtronic has received a total of two complaints concerning this issue from patients implanted with a Vanta INS, both of which have resulted in explant procedures.

What to do

FDA enforcement status: Ongoing

Brands named

medtronic neuromodulationmedtronic

UPCs

0076300041192300763000478087

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →
Vanta with AdaptiveStim Implantable Neurostimulator, Model 977006; spinal chord stimulation — Recall Details · AllClear